ASSOCIATED PRESS — WASHINGTON (AP) — An analysis by U.S. regulators says Johnson & Johnson's single-dose vaccine provides strong protection against severe COVID-19. The report Wednesday confirmed that overall the vaccine is about 66% effective at preventing moderate to severe COVID-19. On Friday, a panel of experts to the Food and Drug Administration will debate if the evidence is strong enough to recommend the long-anticipated shot. The FDA is expected to make a final decision within days. If the FDA clears the J&J shot for U.S. use, it won’t boost vaccine supplies significantly right away. Only a few million doses are expected to be ready for shipping in the first week.
Posted
and last updated
Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.
,
Weather
Monday
01/13/2025
Clear
-° / 36°
0%
Tuesday
01/14/2025
Clear
64° / 37°
0%
Wednesday
01/15/2025
Clear
68° / 37°
0%
Thursday
01/16/2025
Clear
67° / 39°
0%
Friday
01/17/2025
Clear
65° / 38°
3%
Saturday
01/18/2025
Mostly Clear
61° / 38°
17%
Sunday
01/19/2025
Clear
59° / 34°
6%
Monday
01/20/2025
Mostly Clear
58° / 33°
1%